324 related articles for article (PubMed ID: 14707073)
1. In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD8+ T cells.
Morgan DJ; Nugent CT; Raveney BJ; Sherman LA
J Immunol; 2004 Jan; 172(2):1000-8. PubMed ID: 14707073
[TBL] [Abstract][Full Text] [Related]
2. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
3. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
4. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
Kanagawa O; Shimizu J; Vaupel BA
J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
[TBL] [Abstract][Full Text] [Related]
5. Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8+ T cells in nonobese diabetic mice.
Serreze DV; Choisy-Rossi CM; Grier AE; Holl TM; Chapman HD; Gahagan JR; Osborne MA; Zhang W; King BL; Brown A; Roopenian D; Marron MP
J Immunol; 2008 Mar; 180(5):3250-9. PubMed ID: 18292549
[TBL] [Abstract][Full Text] [Related]
6. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience.
Choisy-Rossi CM; Holl TM; Pierce MA; Chapman HD; Serreze DV
J Immunol; 2004 Sep; 173(6):3791-800. PubMed ID: 15356126
[TBL] [Abstract][Full Text] [Related]
7. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
8. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
Eshima K; Suzuki H; Shinohara N
J Immunol; 2006 Feb; 176(3):1628-36. PubMed ID: 16424192
[TBL] [Abstract][Full Text] [Related]
9. Self-specific MHC class II-restricted CD4-CD8- T cells that escape deletion and lack regulatory activity.
Viret C; Janeway CA
J Immunol; 2003 Jan; 170(1):201-9. PubMed ID: 12496401
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T lymphocytes in double alpha beta TCR transgenic mice. I. TCR expression and thymus selection in the absence or in the presence of self-antigen.
Legrand N; Freitas AA
J Immunol; 2001 Dec; 167(11):6150-7. PubMed ID: 11714774
[TBL] [Abstract][Full Text] [Related]
11. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts.
Vizler C; Bercovici N; Heurtier A; Pardigon N; Goude K; Bailly K; Combadière C; Liblau RS
J Immunol; 2000 Dec; 165(11):6314-21. PubMed ID: 11086068
[TBL] [Abstract][Full Text] [Related]
12. A role for accessibility to self-peptide-self-MHC complexes in intrathymic negative selection.
Viret C; Sant'Angelo DB; He X; Ramaswamy H; Janeway CA
J Immunol; 2001 Apr; 166(7):4429-37. PubMed ID: 11254698
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas.
Nugent CT; Morgan DJ; Biggs JA; Ko A; Pilip IM; Pamer EG; Sherman LA
J Immunol; 2000 Jan; 164(1):191-200. PubMed ID: 10605011
[TBL] [Abstract][Full Text] [Related]
14. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
Schmidt D; Verdaguer J; Averill N; Santamaria P
J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
[TBL] [Abstract][Full Text] [Related]
15. Human CD4 expression at the late single-positive stage of thymic development supports T cell maturation and peripheral export in CD4-deficient mice.
Boyer O; Marodon G; Cohen JL; Lejeune L; Irinopoulou T; Liblau R; Bruneval P; Klatzmann D
J Immunol; 2002 Oct; 169(8):4347-53. PubMed ID: 12370367
[TBL] [Abstract][Full Text] [Related]
16. Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions.
Urban JA; Winandy S
J Immunol; 2004 Oct; 173(7):4470-8. PubMed ID: 15383578
[TBL] [Abstract][Full Text] [Related]
17. Peptide specificity of thymic selection of CD4+CD25+ T cells.
Pacholczyk R; Kraj P; Ignatowicz L
J Immunol; 2002 Jan; 168(2):613-20. PubMed ID: 11777953
[TBL] [Abstract][Full Text] [Related]
18. Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype AI4.
Takaki T; Lieberman SM; Holl TM; Han B; Santamaria P; Serreze DV; DiLorenzo TP
J Immunol; 2004 Aug; 173(4):2530-41. PubMed ID: 15294969
[TBL] [Abstract][Full Text] [Related]
19. Analyzing expression of perforin, Runx3, and Thpok genes during positive selection reveals activation of CD8-differentiation programs by MHC II-signaled thymocytes.
Liu X; Taylor BJ; Sun G; Bosselut R
J Immunol; 2005 Oct; 175(7):4465-74. PubMed ID: 16177089
[TBL] [Abstract][Full Text] [Related]
20. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens.
Morgan DJ; Kreuwel HT; Sherman LA
J Immunol; 1999 Jul; 163(2):723-7. PubMed ID: 10395663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
